Aberdeen, United Kingdom

Wael Houssen Ibrahim

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Oxford University Innovation Ltd, University Court of the University of St. Andrews, University of Aberdeen. Active years: 2019-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wael Houssen Ibrahim. Retrieved from https://idiyas.com/inventor/wael-houssen-ibrahim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Wael Houssen Ibrahim

Introduction

Wael Houssen Ibrahim is a notable inventor based in Aberdeen, GB. He has made significant contributions to the field of biotechnology and chemical synthesis, holding two patents that showcase his innovative spirit and expertise.

Latest Patents

One of his latest patents is titled "Modified Heterocyclase." This invention relates to an engineered leader-independent heterocyclase, also known as a cyclodehydratase. It comprises a defined cyanobactin leader sequence that drives the efficient conversion of heterocyclisable amino acids, such as Ser, Thr, and Cys, within a peptide substrate lacking a leader sequence into heterocycles. This invention may be useful in biotechnology and chemical synthesis. Another significant patent is for the "In Vitro Production of Cyclic Peptides." This invention focuses on the in vitro production of cyclic peptides using cyanobacterial enzymes, such as patellamide biosynthesis enzymes. Linear peptide substrates are cyclized using an isolated cyanobacterial macrocyclase, such as PatG. Before cyclization, residues in the linear peptide substrates may be heterocyclized using isolated cyanobacterial heterocyclasses, such as PatD or TruD heterocyclase. The methods of this invention may be beneficial for the production of cyclic peptidyl molecules, including cyclotides and cyanobactins, for use in the development of therapeutics.

Career Highlights

Wael Houssen Ibrahim has worked with reputable organizations, including Oxford University Innovation Limited and the University Court of the University of Aberdeen. His work in these institutions has allowed him to further his research and contribute to advancements in his field.

Collaborations

He has collaborated with notable individuals such as Marcel Jaspars and James Naismith, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Wael Houssen Ibrahim's innovative contributions to biotechnology and chemical synthesis through his patents demonstrate his commitment to advancing scientific knowledge and practical applications. His work continues to inspire future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…